ARCHIVES

Efaproxyn Improved Survival Of Patients With Brain Mets

This article is from The Cancer Letter archive.

Vol. 27 No. 10 | October 29, 2004

Download PDF Visit The Full Archive

Related Articles

Other Contract Concepts Approved By DCE Board

March 10, 1989

Fox Chase Cancer Center Board Selects Michael Seiden of Dana-Farber/Harvard As New President.

March 23, 2007

In Brief: Hong to Retire After 30 Years at MD Anderson

February 14, 2014

In Brief: Kennedy, Waxman May Agree On Simple Extension Of Biomedical Research Authority, Including NCI

November 21, 1980

Switching to Tasigna After Gleevec Therapy Can Achieve Deeper Molecular Response

December 28, 2012

California Hospital Raises $22 Million For New Cancer Center

September 14, 1990